Mizajou Règleman Non-Diskriminasyon

Boston Medical Center Health System konfòm ak lwa federal dwa sivil ki aplikab yo epi li pa fè diskriminasyon sou baz laj, ras, koulè, orijin nasyonal (ki gen ladan konpetans limite angle ak lang prensipal), relijyon, kilti, andikap fizik oswa mantal, sitiyasyon sosyoekonomik, sèks, oryantasyon seksyèl ak idantite sèks ak/oswa ekspresyon. BMCHS bay èd ak sèvis gratis pou moun ki gen andikap ak sèvis lang gratis pou moun ki gen lang prensipal pa angle.

Pou li tout Deklarasyon sou Non Diskriminasyon nou an, klike isit la.

Boston Medical Center Press Releases

Project RED Reduces Hospital Readmissions for Patients with Depressive Symptoms

BOSTON - Results from a new study at Boston Medical Center show how transition support and post-discharge depression treatment reduce unplanned hospital readmissions for individuals with depressive symptoms. Published in Annals of Family Medicine, researchers discovered a 70 and 48 percent reduction in hospital re-admittance at the 30- and 90-day mark following post-discharge care by an adapted version of the Re-Engineered Discharge (RED) Program, a nationally disseminated readmission reduction program, amongst adherents to the program. The adapted version is named RED for Depression (RED-D).

Bridge Clinic Model for Methadone Initiation Leads to High Linkage and Retention in Opioid Treatment

BOSTON – According to a new study from Boston Medical Center’s Grayken Center for Addiction, methadone administration for opioid withdrawal with direct opioid treatment program admission under the “72-hour rule” is possible in an outpatient bridge clinic and resulted in a high number of completed referrals to opioid treatment programs, along with high one-month retention rates. The findings in Drug and Alcohol Dependence show that a hospital-based bridge clinic model of care has the potential to improve methadone access amid the highest rates of opioid overdose death in U.S. history.

Community-Focused Strategy Improves Vaccine Uptake in Black and Latino Communities

BOSTON – New research from Boston Medical Center (BMC) shows how intentionality and partnership between community leaders and medical health centers can improve COVID-19 vaccination uptake in Black and Latino communities. Published in Annals of Internal Medicine, researchers analyzed the impact that a community-focused model led by BMC and its community partners had on improving equitable access to vaccination.

CHAMPS Decreases Racial Inequities in Mississippi Breastfeeding Rates through Public Health Program

BOSTON – New research from Boston Medical Center assesses the impact of a statewide effort to improve breastfeeding rates in Mississippi, using an evidence-based strategy to evaluate the Communities and Hospitals Advancing Maternity Practices (CHAMPS) program. Published in Maternal & Child Nutrition, this study uses the Reach, Effectiveness, Adoption, Implementation and Maintenance (RE-AIM) framework to assess the impact of the program for improving breastfeeding rates in birthing hospitals and the community. RE-AIM has been used to assess the impact of public health programs applied across a range of settings, but no national breastfeeding programs in the U.S., like CHAMPS, have been assessed using an established implementation science framework.

Inflammation markers associated with COVID-19 during pregnancy may signal adverse impacts to long-term infant health

BOSTON – New research results demonstrate how inflammation from a COVID-19 infection during pregnancy could potentially impact long-term infant health, including infant growth and brain development. Published in the Journal of Perinatology, a new study from Boston Medical Center describes how infants of mothers who had a COVID-19 infection during pregnancy had significant elevations in inflammatory blood markers, also known as cytokines, at the time of delivery.

Antibody function antibody dependent cellular cytotoxicity (ADCC) may help prevent the transmission of HIV from mother to child during breastfeeding

BOSTON – According to new research from Boston Medical Center, the antibody function known as antibody dependent cellular cytotoxicity (ADCC) and the ADCC sensitivity of HIV strains may influence the transmission of HIV from mother to child during breastfeeding. These data imply that enhancing ADCC, through a vaccine, for example, may not be sufficient to prevent transmission because chronically infected individuals can harbor ADCC-resistant strains. Published in JCI Insight, the findings provide novel insights about immunologic characteristics that a vaccine may need to elicit to help block HIV transmission.